Skip to content

Follow-up of sequelae and mortality in survivors of Covid-19 patients

Follow-up of sequelae and mortality in survivors of Covid-19 patients - Follow-up of sequelae and mortality in survivors of Covid-19 patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065041
Enrollment
Unknown
Registered
2022-10-26
Start date
2022-10-29
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:None

Sponsors

Shidong Hospital, Yangpu District of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.COVID-19 Patients discharged from Shidong Hospital between February 18,2022 and June 15,2022. 2.More than 16 years old.

Exclusion criteria

Exclusion criteria: 1. Participants who refused; 2. Patients who could not be contacted.

Design outcomes

Primary

MeasureTime frame
sequelea;mortality;

Secondary

MeasureTime frame
Rebound and reinfection;

Countries

China

Contacts

Public ContactYu Wang

Shidong Hospital, Yangpu District of Shanghai

wangyushidonghos@163.com15000023010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026